Status:
COMPLETED
Evaluating Ketamine and Psychological Sequelae
Lead Sponsor:
Defense and Veterans Center for Integrative Pain Management
Conditions:
Pain, Ketamine Infusion, Psychologic Sequelae
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to examine the relationship between the use of intravenous infusion of sub-anesthetic dosages of ketamine given for pain to combat casualties and emerging symptoms of Post...
Detailed Description
The purpose of this study is to examine the relationship between the use of intravenous infusion of sub-anesthetic dosages of ketamine given for pain to combat casualties and emerging symptoms of Post...
Eligibility Criteria
Inclusion
- Group I. Ketamine Group
- Active duty military service member injured in theater and treated at WRAMC or at WRNMMC
- 18 years of age or older
- Completed the PBBHA or PDHAT initial and follow up assessment post aerovac from theater
- Received ketamine infusion to treat pain after aero-evacuation for inpatient medical care between Sep 2005 and June 2014
- Received ketamine before completion of the PDHAT or PDBHA follow-up assessment
- ISS scores are available for each individual
- Group II. Non-Ketamine Comparison Group
- Active duty military service member injured in theater and treated at WRAMC or at WRNMMC
- 18 years of age or older
- Completed the PBBHA or PDHAT initial and follow up assessment post aerovac from theater
- Did not receive ketamine treatment for pain after aero-evacuation for inpatient medical care before follow-up
- ISS are available for each individual
- Patient will have ISS scores similar to a Ketamine Group patient and a similar timing of injury to the same Ketamine Group patient.
Exclusion
- Not treated by WRNMMC/WRAMC hospital staff between Sep 2005 and June 2014
- Not active duty, activated National Guard, or activated Reserve service members
- Younger than 18 years of age
- Did not complete the PDBHA or PDHAT initial and follow-up assessments
- ISS scores are not available
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 13 2017
Estimated Enrollment :
159 Patients enrolled
Trial Details
Trial ID
NCT04053400
Start Date
December 1 2014
End Date
September 13 2017
Last Update
August 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Walter Reed National Military Medical Center
Bethesda, Maryland, United States, 20889